Aneurysm Coiling and Embolization Devices Market by Product and Geography - Forecast and Analysis 2022-2026

The aneurysm coiling and embolization devices market share is expected to increase by USD 1.87 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.06%. This aneurysm coiling and embolization devices market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The aneurysm coiling and embolization devices market report also offers information on several market vendors, including Acandis GmbH, Asahi Intecc Co. Ltd., B Braun Melsungen AG, BALT Group, Braile Biomedica, Cook Group Inc., Integer Holdings Corp., Johnson and Johnson, Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corp., Penumbra Inc., phenox GmbH, Stryker Corp., Terumo Corp., and Medtronic Plc among others. Furthermore, this report extensively covers aneurysm coiling and embolization devices market segmentation by product (embolization coils, access and delivery services, aneurysm clips, balloon and stent assisted coils, and flow diversion devices) and geography (North America, Europe, Asia, and Rest of World (ROW)).

What will the Aneurysm Coiling and Embolization Devices Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Aneurysm Coiling and Embolization Devices Market Size for the Forecast Period and Other Important Statistics

 

Aneurysm Coiling and Embolization Devices Market: Key Drivers, Trends, and Challenges

The increasing prevalence of IAs and associated risk factors is notably driving the aneurysm coiling and embolization devices market growth, although factors such as high cost of treatment may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the aneurysm coiling and embolization devices industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Aneurysm Coiling and Embolization Devices Market Driver

One of the key factors driving the global aneurysm coiling and embolization devices industry growth is the increasing prevalence of IAs and associated risks. For instance, the global prevalence of IAs is around 75 per every 1,000 individuals, and the annual incidence of reported ruptured aneurysms is about 100 in every million people. The estimated worldwide incidence of subarachnoid hemorrhage (SAH) is 90 per million people per year with regional variation.; 20 out of every 1,000 people in the US will develop an unruptured IA in their lifetime. Furthermore, if a patient has an aneurysm, there is nearly a 20% likelihood that the person will have one or more additional aneurysms. Other risk factors associated with IAs, including hypertension, smoking, and chronic alcohol use, are also on the rise. This, in turn, is leading to an increase in the prevalence of IAs, which will drive market growth in the forecast period.

Key Aneurysm Coiling and Embolization Devices Market Trend

Growing demand for flow diversion as an alternative to neurovascular coiling is one of the key aneurysm coiling and embolization devices market trends that is expected to impact the industry positively in the forecast period. Flow diversion procedures are associated with a low complication rate, high cure rate, and increased safety. Furthermore, they reduce the chances of a patient developing another aneurysm, require a shorter recovery period, and involve lesser radiation exposure when compared with other endovascular techniques. Also, FDS provides better neck reconstruction and reduces the need for retreatment and the rate of long-term recanalization when compared with conventional endovascular embolization with coils alone or coils in combination with stents. Furthermore, the use of FDS such as the Pipeline Embolization Device is more cost-effective than traditional SAC for the treatment of large anterior circulation aneurysms. Hence, the increase in demand for flow diversion procedures will be driving the market growth.

Key Aneurysm Coiling and Embolization Devices Market Challenge

One of the key challenges to the global aneurysm coiling and embolization devices industry growth is the high cost of treatment. In the US, the average one-year total cost for a patient with an IA treated by clipping is around USD 42,000. The average cost of neuroendovascular coiling for a patient with ruptured IA for one year is nearly USD 45,000. The cost of a stent used in SAC is around USD 5,000 to USD 5,500. Patients treated with SAC require significantly more coils than patients who undergo coiling alone. In the US, the hospitalization costs for patients undergoing clipping and coiling of unruptured IAs are significantly higher than Medicare payments. Furthermore, many countries, especially in Asia and MENA (the Middle East and North Africa), offer limited or no reimbursements for neuroendovascular coiling and stenting procedures. Such factors will limit the market growth in the forecast period.

This aneurysm coiling and embolization devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global aneurysm coiling and embolization devices market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the aneurysm coiling and embolization devices market during the forecast period.

Who are the Major Aneurysm Coiling and Embolization Devices Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Acandis GmbH
• Asahi Intecc Co. Ltd.
• B Braun Melsungen AG
• BALT Group
• Braile Biomedica
• Cook Group Inc.
• Integer Holdings Corp.
• Johnson and Johnson
• Kaneka Corp.
• Lepu Medical Technology Beijing Co. Ltd.
• MicroPort Scientific Corp.
• Penumbra Inc.
• phenox GmbH
• Stryker Corp.
• Terumo Corp.
• Medtronic Plc

 

This statistical study of the aneurysm coiling and embolization devices market encompasses successful business strategies deployed by the key vendors. The aneurysm coiling and embolization devices market is fragmented and the vendors are deploying growth strategies such as investment in research and development (R and D) to compete in the market.

Product Insights and News

• Acandis GmbH - The company offers aneurysm coiling and embolization devices such as ACCERO Stent, ACCLINO flex plus Stent, DERIVO, and DERIVO mini Embolisation Device. ACCERO Stent is a highly visible, braided self-expanding stent with BlueXide surface finishing. ACCLINO flex plus Stent is a highly flexible self-expanding, laser-cut nitinol stent with an asymmetric cell design. DERIVO devices are advanced flow diversion with a unique visibility concept. 
• Acandis GmbH - Through the catheters segment, the company offers NeuroSlider Microcatheters,  NuroBridge Intermediate Catheters, and NuroSpeed PTA Balloon Catheters. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The aneurysm coiling and embolization devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Aneurysm Coiling and Embolization Devices Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the aneurysm coiling and embolization devices market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Aneurysm Coiling and Embolization Devices Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for aneurysm coiling and embolization devices in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The increasing number of neuro-endovascular coiling and stenting procedures, the strong presence of established vendors, increased healthcare expenditure, and the increasing prevalence of IAs and related risk factors will facilitate the aneurysm coiling and embolization devices market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In early 2020, the outbreak of COVID-19 in the region brought operations in manufacturing facilities, regulatory approvals, and vascular treatments to a halt, which restricted the production and use of aneurysm coiling and embolization devices and negatively impacted the growth of the market in the region. However, in 2021, following the initiation of mass COVID-19 vaccination drives, the market was expected to grow. The pandemic, which has claimed over 860,113 lives in the US as of January 23, 2022, has prompted vendors to adopt new business strategies, such as online promotional activities and training for doctors, to meet the high demand for aneurysm coil embolization devices. This will help the regional aneurysm coil embolization device market grow during the forecast period.

What are the Revenue-generating Product Segments in the Aneurysm Coiling and Embolization Devices Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The aneurysm coiling and embolization devices market share growth by the embolization coils segment will be significant during the forecast period. Factors such as the rising number of endovascular coiling procedures, increasing patients' preference toward minimally invasive surgeries, and technological advances will drive the growth of the segment in the coming years.

This report provides an accurate prediction of the contribution of all the segments to the growth of the aneurysm coiling and embolization devices market size and actionable market insights on post COVID-19 impact on each segment.

 

Aneurysm Coiling and Embolization Devices Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 9.06%
Market growth 2022-2026	$ 1.87 billion
Market structure	Fragmented
YoY growth (%)	6.44
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 39%
Key consumer countries	US, Canada, Denmark, China, and India
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Acandis GmbH, Asahi Intecc Co. Ltd., B Braun Melsungen AG, BALT Group, Braile Biomedica, Cook Group Inc., Integer Holdings Corp., Johnson and Johnson, Kaneka Corp., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corp., Penumbra Inc., phenox GmbH, Stryker Corp., Terumo Corp., and Medtronic Plc
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Aneurysm Coiling and Embolization Devices Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive aneurysm coiling and embolization devices market growth during the next five years
• Precise estimation of the aneurysm coiling and embolization devices market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the aneurysm coiling and embolization devices industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of aneurysm coiling and embolization devices market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch